Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Daily Stock Ratings & Price Targets US

Daily stock ratings from over 8,000 Wall Street analysts

Analysts' Top Stocks

Top Smart Score Stocks

Stock Screener

Daily Analyst Ratings

Trending Stocks

Penny Stocks Screener

Insider Hot Stocks

Daily Buy Ratings

Analyst & Firm	Company	Rating & Price Target	Upside / Downside
Alexei GogolevJ.P. Morgan	APPF AppFolio	BUY$328	57.30% Upside
Brian NagelOppenheimer	PTON Peloton Interactive	BUY$20	175.86% Upside
Alex RygielB.Riley Financial	ORN Orion Group Holdings	BUY$10	58.73% Upside
Timothy ArcuriUBS	ALGM Allegro MicroSystems	BUY$30	42.18% Upside

Daily Sell Ratings

Analyst & Firm	Company	Rating & Price Target	Upside / Downside
Bascome MajorsSusquehanna	WERN Werner Enterprises	SELL$28	-25.41% Downside
Toshiya HariGoldman Sachs	COHU Cohu	SELL$23	-15.90% Downside
Kate McShaneGoldman Sachs	GO Grocery Outlet Holding	SELL$15	-0.33% Downside
Jerry RevichGoldman Sachs	MTW Manitowoc Company	SELL$9.7	8.99% Upside

Full List of Stock Ratings

(Nov 3, 2024)

Analyst Performance

Any

Analyst Rating

Any

Upside / Downside

Any

Action

Any

Market Cap

Any

Analyst & Firm	Company	Rating & Price Target	Upside / Downside	Average Return	Action	Date	Article
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY	―	9.80%	Reiterated	2024-11-03
Daniel AriasStifel Nicolaus	CDXS Codexis	BUY $5	―	-9.00%	Reiterated	2024-11-01	Codexis (CDXS) Receives a Buy from Stifel Nicolaus
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $150	―	24.30%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $10.5	―	19.10%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $190→$225	―	17.10%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $120→$124	―	14.00%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $28	―	8.20%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $147→$83	―	36.70%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $329	―	7.90%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $251→$260	―	13.20%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $172	―	18.20%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $160	―	14.70%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $58	―	5.50%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $50	―	1.20%	Assigned	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $42	―	10.40%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $33.75	―	9.90%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $1,042	―	20.20%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $203→$215	―	13.20%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $130	―	25.30%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $47→$59	―	6.30%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $11	―	9.30%	Assigned	2024-11-01
Eliana MerleUBS	MDGL Madrigal Pharmaceuticals	BUY $411→$441	―	-5.50%	Reiterated	2024-11-01	Madrigal Pharmaceuticals price target raised to $441 from $411 at UBS
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $232→$227	―	3.90%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $103→$110	―	6.20%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $49→$54	―	18.30%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $45→$36	―	11.00%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $225→$232	―	30.20%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $25	―	22.40%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $235	―	13.80%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $9	―	62.50%	Assigned	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $66	―	10.40%	Assigned	2024-11-01
Laurence AlexanderJefferies	LIN Linde	BUY $550	―	0.00%	Reiterated	2024-11-01	Linde (LIN): New Buy Recommendation for This Basic Materials Giant
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $406	―	10.90%	Assigned	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $170	―	2.50%	Reiterated	2024-11-01
Michael YeeJefferies	DNLI Denali Therapeutics	BUY $45	―	-1.30%	Assigned	2024-11-01	Jefferies Sticks to Their Buy Rating for Denali Therapeutics (DNLI)
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $65→$70	―	7.40%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $22→$25	―	10.70%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $260→$280	―	10.40%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $23→$24	―	0.80%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $25→$26	―	31.20%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $35→$29	―	31.20%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $215	―	7.80%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $53	―	0.80%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $118	―	0.80%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $37	―	4.90%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $20	―	7.80%	Reiterated	2024-11-01
Robert OttensteinEvercore ISI	ABEV Ambev SA	BUY $5	―	-0.20%	Reiterated	2024-11-01	Evercore ISI Remains a Buy on Ambev SA (ABEV)
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $75	―	8.90%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $360	―	10.40%	Reiterated	2024-11-01
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $75	―	10.40%	Reiterated	2024-11-01

Rows:

Ready for the Full Picture?Your current plan limits your access to top-tier analyst ratings. Subscribe to Premium now and unlock the full range of ratings from the highest-ranked analysts on Wall Street. Don't let partial views limit your market research potential - upgrade today!

Upgrade Now Plans & Pricing